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Introduction Cardiovascular diseases are a major component of non-communicable 
diseases and include coronary heart disease, stroke and peripheral vascular 
disease. Public health strategies to address cardiovascular disease require 
three elements: surveillance, health promotion, and individual health care.
Methods Surveillance includes monitoring of mortality and morbidity as well as 
surveys to monitor risk factors levels in the community. Data on mortality 
from cardiovascular diseases are readily available and analysed by age and 
sex specific rates looking are secular trends, geographical and ethnical group 
variations and international comparisons. However many deaths from 
cardiovascular disease occur suddenly and the cause of death may be 
registered without autopsy or any other validation. Cardiovascular morbidity 
information is more difficult to collate and interpret as it is closely related to 
availability and access to health care. Periodic surveys of cardiovascular risk 
factors are essential in monitoring the underlying trends in blood pressure, 
smoking, cholesterol, obesity, and diabetes as they predict future trends, and 
support planning for prevention and healthcare.
Results Prevention and health promotion activities are informed by the levels and 
trends in cardiovascular disease and its risk factors. There has been debate 
about population health promotion and individual health care strategies, but 
both are necessary. Cigarette smoking, nutrition and physical exercise are the 
main behaviours to be addressed but these are complex and require 
multifaceted approaches. Education alone is insufficient to change health 
behaviours and health promotion needs to look to changing attitudes. 
Legislation, taxation and other fiscal interventions have been shown to be 
effective however these can be difficult for legislators as there are other 
competing interests, particularly in the area of nutrition and tobacco. Creating 
health promoting environments that make healthy behaviour choices easier 
can be beneficial.
Conclusions Health care interventions are also effective in reducing the burden of 
cardiovascular disease. A balanced approach of health promotion and 
individual health care is recommended in the development of a strategy for 
cardiovascular disease.
Keywords Cardiovascular disease - Non-communicable disease - Public health.
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INTRODUCTION
Cardiovascular diseases are a major component of 
non-communicable diseases and include coronary 
heart disease, stroke and peripheral vascular 
disease. There is a long history of cardiovascular 
diseases in high income countries with western 
cultures over the last 100 years where they have 
become the most common cause of mortality. 
However cardiovascular diseases are increasingly 
common globally and have become a major threat 
to health in low and middle income countries. Non-
communicable diseases were not included in the 
Millennium Development Goals of 2000 which 
focussed on the communicable diseases of 
HIV/Aids, tuberculosis and malaria. It is now 
recognised that nearly 80% of deaths from non-
communicable diseases occur in low and middle 
income countries 1.
Cardiovascular diseases include coronary 
heart disease, stroke, and peripheral vascular 
disease. Coronary heart disease presents as a 
number of clinical entities such as acute myocardial 
infarction, angina pectoris, heart failure, 
arrhythmias and sudden death. Cardiovascular 
diseases are not only a major cause of mortality but 
also of morbidity; they are responsible for loss of 
productivity, and have an impact on the economy 
as well as on the individual and their families. They 
result in residual disability and have a considerable 
impact on the health services.
National strategies to address 
cardiovascular diseases overlap with strategies for 
non-communicable diseases as there are several 
risk factors in common including diet, physical 
activities and tobacco smoking1. This paper aims to 
describe the public health strategy needed to 
address cardiovascular disease which needs three 
elements: surveillance, prevention and health 
promotion, and individual health care.
Surveillance
Surveillance includes monitoring of mortality, 
morbidity and use of health services as well as 
regular surveys of risk factors.
i) Mortality
Data on mortality from cardiovascular diseases are 
readily available and are normally analysed by age 
and sex specific rates looking at secular trends, 
geographical and ethnic group variations and 
international comparisons. Many deaths from 
cardiovascular disease occur suddenly and the 
cause of death may be registered without autopsy 
or any other validation. In some settings 
registration of cause of death may not be complete. 
There may also be regional variations as well as 
secular trends in how diseases are defined and 
classified and periodic changes are made in the 
International Classification of Diseases. However, 
despite these limitations, there is value in 
reviewing the data on cardiovascular disease 
mortality rates. Figure 1 shows the standardised 
death rates from cardiovascular mortality and 
diabetes in 2008 for a number of selected 
countries2. Traditionally cardiovascular diseases 
have been characteristic of western cultures with 
high rates in North America and in Europe, 
especially Scotland and Finland3. However there 
have been very considerable declines in 
cardiovascular disease death rates in Europe over 
the last 25 years, for example declines of 54% in 
Finland and over 60% in UK, Ireland and Sweden4.
In contrast there have been substantial increases in
the Commonwealth of Independent States such as 
Belarus and Ukraine, and in East Asia. The rise in 
non-communicable diseases including 
cardiovascular diseases in some former Soviet 
Union areas has resulted in a decrease in life 
expectancy5. These death rates in middle and lower 
income countries are projected to rise by over 50% 
by 2030. The death rate from cardiovascular 
diseases and diabetes in Malaysia is now much 
higher than Europe, USA and Australia in both 
men and women.  
ii) Morbidity
Cardiovascular morbidity information is more 
difficult to collate and interpret than cardiovascular 
mortality data. Accurate incidence data on 
cardiovascular events require disease registers, 
robust diagnostic criteria, and completeness of 
ascertainment all of which is challenging for many 
health systems. International studies such as the 
WHO MONICA project have measured incidence 
in selected populations within countries6. 
Prevalence at one point in time can be measured in 
prevalence surveys of risk risks in population 
samples. Prevalence of chronic manifestations such 
as angina pectoris and claudication can be 
estimated by prevalence surveys, however it is 
important that standardised, validated methods are 
used which allow international comparisons and 
assessment of trends over time6.
iii) Risk Factors
Periodic surveys of cardiovascular risk factors are 
essential in monitoring the underlying trends in 
blood pressure, smoking, cholesterol, obesity, and 
diabetes. Levels and trends in disease and its risk 
factors are important intelligence in predicting 
future trends, and planning prevention 
programmes. Current risk factor trend analysis in 
Malaysia show adverse trends for blood pressure, 
fasting blood glucose, total cholesterol and body 
mass index7. WHO has developed a framework for 
monitoring non-communicable diseases and their 
risk factors4 and has developed the STEPS 
approach8 to develop comprehensive risk profiles at 
a national level.
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The age standardised adjusted estimates 
for current daily tobacco smoking for the same 
selected countries are shown in Figure 26. The 
figure shows a relationship between male smoking 
and death rates from cardiovascular disease and 
diabetes in men shown in Figure 1. With the 
exceptions of Saudi Arabia and the Republic of 
South Africa the countries with high mortality are 
also the countries with a high prevalence of 
tobacco smoking. However the European countries 
previously had similarly high levels of tobacco use 
which have now decreased while the trend has been 
increasing in Asia countries. The pattern of women 
smoking in Europe tends to be similar to the pattern 
in men while in Asia the uptake of smoking by 
women has remained low, it is important that this is 
maintained.
Figure 1 Age Standardized Death Rates per 100,000 from Cardiovascular Disease and Diabetes (2008) 
Source: WHO 20102
Figure 2 Ages Standardized Adjusted Estimates of Current Daily Tobacco Smoking 
Source: WHO 20102
In 2011, similar health and morbidity 
surveys were conducted in both Malaysia and 
Scotland9,10. The similarities and differences are 
interesting and these are presented in Table 1. The 
proportions of the populations with hypertension 
are similar but over 60% of those in Malaysia are 
undetected while only 17% in Scotland are 
untreated. Earlier surveys in Scotland had shown 
high levels of under-diagnosis and under-treatment 
hypertension but the detection and management of 
hypertension has now greatly improved11. The 
proportion with diabetes in Malaysia is around 
double that in Scotland but over half of those in 
Malaysia are undetected while the figure in 
Scotland is 30%. The differences in diabetes are 
not explained by differences in Body Mass Indices 
(BMI) since in Scotland 64% have BMIs of 25 
Kg/m2 or more compared to 45% in Malaysia. 
Other factors such genetics and nutrition is clearly 
important and this observation has been 
investigated in previous surveys12. Successive 
surveys in Malaysia have shown increasing 
proportions of the population with diabetes9.
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Table 1 Disease prevalence in adults: results from Health Surveys in Malaysia and Scotland (2011)
Men Women Undetected
Hypertension
        Malaysia 34% 32% 61%
        Scotland 33% 32% 17% (Untreated)
Diabetes
        Malaysia 15.8% 14.6% 53%
        Scotland 8.7% 7.0% 30%
Hypertension: Self reported plus average blood pressures equal or greater than 140/90 mmHg
Diabetes: Self reported plus fasting blood glucose (Malaysia) and glycated haemoglobin (Scotland) 
Source: References9, 10
iv) Health systems response
Information on the use of health services such as 
admissions for coronary syndromes, prescribing of 
cardiovascular drugs and interventions such 
angioplasty can be used to assess cardiovascular 
morbidity. These data are difficult to interpret as 
they are closely related to availability and access to 
health care and may not reflect need. However such 
information has value for the planning of health 
services and for monitoring their uptake reflecting 
demand and access to healthcare.   
Prevention and Health Promotion
Prevention of non-communicable diseases 
including cardiovascular diseases is an important 
political issue13 and this is reflected in the WHO –
Malaysia country cooperation strategy 2009-
201314. The focus of prevention and health 
promotion activities is based on the data on the 
levels and trends in cardiovascular disease and its 
risk factors. There has been debate about 
population health promotion and individual health 
care strategies, but is clear both are necessary.
Cigarette smoking, nutrition and physical exercise 
are the main behaviours to be addressed but these 
are complex and require multifaceted approaches. 
Education alone is insufficient to change health 
behaviours and health promotion needs to look to 
changing attitudes. Legislation, taxation and other 
fiscal interventions have been shown to be effective 
however these can be difficult for legislators as 
there are other competing interests, particularly in 
the area of nutrition and tobacco. The banning of 
smoking in public areas has been widely accepted 
however it is only one step in a long battle.
Countries trying implement minimum pricing on 
alcohol and advertising bans face many legal and 
political challenges15. Creating health promoting 
environments that make healthy behaviour choices 
easier can be beneficial, particularly related to 
smoking bans and opportunities for physical 
exercise. Health promotion actions can target 
specific groups such as schools, occupational 
settings and hard to reach groups such as young 
adults.
i) Multi-sectoral approach
The impact of cardiovascular diseases and diabetes 
is not just on the health of individuals and 
populations but also impacts on the economy 
through reduced productivity, and increased costs 
of health care. It is therefore important that 
multisectoral approaches are employed in the 
prevention of cardiovascular disease16. The 
approaches involve not only the health care sector 
but also education, agriculture, the environment, 
transport, urban planning, leisure and recreation 
and industry. 
ii) Legislation and Fiscal approaches
Legislation and fiscal measures are important in the 
control of tobacco and alcohol use through age 
restrictions, restrictions on sales, use in public 
places, taxation, protecting people from secondary 
smoke, health warnings and bans on advertising 
These approaches can be extended to unhealthy 
diets and physical inactivity through legislation, 
taxation on unhealthy foods, food labelling and 
subsidies on healthy foods17. Legal controls on 
emissions to reduce air pollution can also have a 
benefit for cardiovascular health.
iii) Education and Information
Education and information are important aspects of 
prevention and health promotion but need to be 
supported by legislation, fiscal measures and the 
promotion of environments making healthy choices 
easier. This includes education through the 
curricula for schools and colleges but also 
approaches to the wider community through the 
media such as newspapers, radio and television. 
iv) Behaviour change 
Changing behaviour in the use of tobacco, alcohol, 
diet, and physical activity is a complex process.
Education is part of the process but creating 
healthy environments, pricing, taxation, and 
legislation are all important in encouraging healthy 
behaviour. Support such as help to quit tobacco use 
is a specific example5. 
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Healthcare
There has been debate over whether health 
promotion or individual health care interventions 
are more effective in reducing the burden of 
cardiovascular disease. Clearly both are important 
and the dilemma has been over which has the 
greatest contribution and which is more cost-
effective. In practice the urgency of clinical need 
has tended to favour funding individual health care 
but it is important that health promotion 
interventions are also resourced and pursued 
vigorously. Acute coronary and stroke care, while 
increasingly effective, are expensive. Management 
of high risk patients and secondary prevention is 
also effective as is management of diabetes and 
individual measures to support smoking cessation. 
A balanced approach of health promotion and 
individual health care is recommended.
Management of risk factors
Primary prevention relates to management of risk 
factors in healthy individuals such as treating 
hypertension or raised blood cholesterol. This 
usually requires some form of screening such as 
population screening, occupational screening, or 
opportunistic screenings when a patient consults 
about other health problems. There is debate about 
the cost-effectiveness of screening and treating 
healthy individuals with a single risk factor because 
of their low absolute risk. Approaches using 
multiple risk factor scores have been advocated to 
identify individuals at higher risk of cardiovascular 
diseases18.
i) Secondary prevention
The evidence of effectiveness of interventions to 
reduce risk in people with existing cardiovascular 
disease is substantial. Interventions include 
behavioural changes such as smoking cessation, 
dietary change, weight management and increase in 
physical activities which are cost effective. 
Management of related co-morbid condition such 
as diabetes and hypertension have benefits. There 
are also effective pharmacological interventions 
that reduce risk of further events such as aspirin, 
cholesterol lowering agents, ACE Inhibitors and 
beta-blockers. Influenza vaccination and cardiac 
rehabilitation also have health benefits. These 
interventions are important as they are cost-
effective in identified individuals who are at 
increased risk19.
ii) Acute care
In the past there has been debate about the relative 
impact of prevention versus treatment on 
cardiovascular disease mortality and morbidity 
rates. An analysis of decreases in cardiovascular 
disease mortality rates in the United States between 
1980 and 2000 estimated that half of the decrease 
was attributable to changes in risk factors and half 
due to medical intervention20. There have been 
rapid developments in the management of acute 
coronary syndromes as well as management of 
acute stroke in specialised stroke units which have 
resulted in reduced mortality and increased survival 
and quality of life. A balanced strategy for 
cardiovascular disease must include the health care 
but consideration needs to be paid to the cost-
effectiveness of the different interventions and the 
cost impact on individuals and health care 
providers.
CONCLUSIONS
A strategy to address cardiovascular diseases 
requires surveillance, prevention/health promotion, 
and health care components. Surveillance includes 
monitoring trends in cardiovascular diseases as 
well as trends in cardiovascular disease risk factors. 
The trends in modifiable cardiovascular disease 
risk factors in many Asia countries including 
Malaysia show adverse trends in hypertension, 
diabetes, obesity, tobacco smoking, and physical 
inactivity. These risk factors trends are a prelude to 
further includes in cardiovascular morbidity and 
mortality, such increases can impact on the 
economy, life expectancy, as well as the health 
individuals. A strategy of managing the increase by 
health care alone is unaffordable and unsustainable. 
A balance strategy must include multi-sectoral 
approaches to health promotion and disease 
prevention to reverse the trends in cardiovascular 
disease.
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